Owlstone Raises £22m to Advance Breath Biopsy Technology
Deal News | Jan 15, 2025 | Business Cloud
Owlstone Medical, a Cambridge-based MedTech company, has successfully raised £22 million in Series E funding to advance its Breath Biopsy platform, which aims to diagnose diseases through non-invasive breath analysis. This capital injection will support ongoing clinical trials for lung cancer detection, further development of at-home liver disease diagnostics, and the commercialization of a low-cost device for digestive disease monitoring. The prominent investors in this funding round include Ventura Capital, Aviva Ventures, Horizons Ventures, and the Gates Foundation. Owlstone has already secured partnerships with notable entities like the US Department of Defence and the FDA, enhancing the credibility of its Breath Biopsy technology. The funds will be instrumental in accelerating the company's efforts to bring these groundbreaking diagnostic tools to market.
Sectors
- Healthcare
- Biotechnology
- Venture Capital
Geography
- United Kingdom – Owlstone Medical is based in Cambridge, UK, and the funding involves UK entities.
- United States – The article mentions partnerships with US organizations like the Department of Defence and FDA.
Industry
- Healthcare – The article discusses medical diagnostics and healthcare technology developments.
- Biotechnology – Owlstone's Breath Biopsy technology is an innovative approach in biotech for disease detection.
- Venture Capital – The article covers a significant Series E funding round led by venture capital firms.
Financials
- £22 million – The amount raised by Owlstone Medical in the Series E funding round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Owlstone Medical | Target Company | Company | A Cambridge-based MedTech company developing Breath Biopsy diagnostics. |
| Ventura Capital | Lead Investor | Company | A venture capital firm leading the £22m Series E funding round for Owlstone. |
| Aviva Ventures | Investor | Company | An investor participating in Owlstone's funding round. |
| Horizons Ventures | Investor | Company | An investor participating in Owlstone's funding round. |
| Gates Foundation | Investor | Charity | A philanthropic organization investing in Owlstone's Series E funding round. |
| Mo El Husseiny | Managing Partner | Person | Founder and managing partner at Ventura Capital. |
| Billy Boyle | Co-founder and CEO | Person | Co-founder and CEO of Owlstone Medical. |